Adherence to the Colombian guideline on congenital toxoplasmosis

Sara Correa-Pérez, Mauricio Daniel Carrascal-Petro, Catalina Arango-Ferreira, Claudia Patricia Beltrán-Arroyave, Javier Mauricio Sierra-Abaunza, .

Keywords: toxoplasmosis, diagnóstico prenatal, toxoplasmosis congénita, salud pública, adhesión a las directivas anticipadas, guía de práctica clínica

Abstract

Introduction. Congenital toxoplasmosis is associated with high morbidity and mortality in the neonatal period. Despite the existence of a Colombian clinical practice guideline for the diagnosis and treatment of gestational and congenital toxoplasmosis, adherence to its recommendations remains unknown.
Objective. To evaluate adherence to the Colombian clinical practice guidelines of congenital and gestational toxoplasmosis in two hospitals in Medellin during 2016-2020.
Materials and methods. We conducted a descriptive study in children under one year of age with suspected or confirmed congenital toxoplasmosis, treated at two hospitals in Medellin between 2016 and 2020. We used proportion measures to assess adherence to the clinical practice guidelines recommendations.
Results. Two hundred and forty-seven children were included; 17% had a confirmed congenital toxoplasmosis diagnosis. Adherence to the different clinical practice guidelines recommendations was variable. To diagnose gestational toxoplasmosis, immunoglobulins G and M serologies were ordered in 85.4% of the cases. Use of other diagnostic tests – depending on the clinical situation– ranged from 20 to 41.5%; amniocentesis was indicated in 42.9% of pregnant women, whereas IgM, IgG, and IgA were ordered for 50.6% of newborns. Spiramycin was prescribed to 68.8% of mothers diagnosed with gestational toxoplasmosis. Among patients diagnosed with congenital toxoplasmosis, 80.9% presented clinical
manifestations; the most common were those of the central nervous system. The highest adherence to the clinical practice guidelines was observed for the treatment of congenital toxoplasmosis (96.7%).
Conclusions. Adherence to the recommendations of the Colombian clinical practice guidelines for congenital and gestational toxoplasmosis is variable, likely due to implementation barriers, such as limited dissemination, insufficient training or updates for healthcare personnel, and challenges in accessing diagnostic studies and ensuring followup. We recommend developing institutional and government policies to provide periodic updates to prenatal care and newborn care personnel.

Downloads

Download data is not yet available.
  • Sara Correa-Pérez Grupo en Investigación Clínica en Enfermedades del Niño y del Adolescente – Pediaciencias, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia; Departamento de Pediatría, Hospital San Vicente Fundación, Medellín, Colombia https://orcid.org/0000-0003-1375-9983
  • Mauricio Daniel Carrascal-Petro Grupo en Investigación Clínica en Enfermedades del Niño y del Adolescente – Pediaciencias, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia; Departamento de Pediatría, Hospital San Vicente Fundación, Medellín, Colombia https://orcid.org/0009-0004-1954-5913
  • Catalina Arango-Ferreira Grupo en Investigación Clínica en Enfermedades del Niño y del Adolescente – Pediaciencias, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia; Departamento de Infectología Pediátrica, Hospital San Vicente Fundación, Medellín, Colombia https://orcid.org/0000-0002-0517-1330
  • Claudia Patricia Beltrán-Arroyave Grupo en Investigación Clínica en Enfermedades del Niño y del Adolescente – Pediaciencias, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia; Departamento de Infectología Pediátrica, Hospital San Vicente Fundación, Medellín, Colombia https://orcid.org/0000-0002-5372-8172
  • Javier Mauricio Sierra-Abaunza Grupo en Investigación Clínica en Enfermedades del Niño y del Adolescente – Pediaciencias, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia; Departamento de Pediatría, Hospital San Vicente Fundación, Medellín, Colombia https://orcid.org/0000-0002-4131-0801

References

Guedez IV, Barroso LA. Caracterización del tratamiento de la toxoplasmosis gestacional. Rev Salud Vive. 2020;3:69-76. https://doi.org/10.33996/revistavive.v3i8.44

Gómez-Sánchez PI, Arévalo-Rodríguez I, Rubio-Romero JA, Guío JA, Osorio-Castaño JH, Buitrago-Gutiérrez G, et al. Guías de Práctica Clínica para la prevención, detección temprana y tratamiento de las complicaciones del embarazo, parto o puerperio. Sección Toxoplasmosis. Bogotá: Ministerio de Salud y Protección Social – Colciencias; 2013. p. 369-400.

Cañón-Franco WA, López-Orozco N, Gómez-Marín JE, Dubey JP. An overview of seventy years of research (1944 - 2014) on toxoplasmosis in Colombia, South America. Parasit Vectors. 2014;7:427. https://doi.org/10.1186/1756-3305-7-427

Franco PS, Morais AC, Silva RJ, Araujo TE, Gonzaga HT, Ferreira C, et al. Systematic review and meta-analysis of congenital toxoplasmosis diagnosis: Advances and challenges. J Trop Med. 2024;1:1-27. https://doi.org/10.1155/2024/1514178

Rosso F, Agudelo A, Isaza Á, Montoya JG. Congenital toxoplasmosis: Clinical and epidemiological aspects of the infection during pregnancy. Colomb Med (Cali). 2007;38:316-37.

Maldonado YA, Read JS, Byington CL, Barnett ED, Davies HD, Edwards KM, et al. Diagnosis, treatment, and prevention of congenital toxoplasmosis in the United States. Pediatrics. 2017;139:1-52. https://doi.org/10.1542/peds.2016-3860

Thiébaut R, Leproust S, Chêne G, Gilbert R, SYROCOT (Systematic Review on Congenital Toxoplasmosis) Study Group. Effectiveness of prenatal treatment for congenital toxoplasmosis: A meta-analysis of individual patients’ data. Lancet. 2007;369:115-22. https://doi.org/10.1016/S0140-6736(07)60072-5

Rueda-Páez YS, Valbuena-Ruiz L, Quintero-Pimiento N, Pinilla-Plata A, Sayago-Silva J. Toxoplasmosis congénita, una mirada en la actualidad del tratamiento; revisión de la literatura. MedUNAB. 2019;22:51-63. https://doi.org/10.29375/01237047.2612

Cortés JA, Gómez JE, Silva PI, Arévalo L, Arévalo I, Álvarez MI, et al. Integral Care Guidelines for the prevention, early detection and treatment of pregnancy, partum, and puerperium complications: Section on toxoplasmosis in pregnancy. Infectio. 2012;16:230-46. https://doi.org/10.1016/S0123-9392(12)70018-8

Barrera A, Castiblanco P, Gómez MJ, López M, Ruiz A, Moncada L, et al. Toxoplasmosis adquirida durante el embarazo en el Instituto Materno Infantil en Bogotá. Rev Public Health. 2002;4:286-93.

Bollani L, Auriti C, Achille C, Garofoli F, De Rose DU, Meroni V, et al. Congenital toxoplasmosis: The state of the art. Front Pediatr. 2022;10:1-12. https://doi.org/10.3389/fped.2022.894573

Peyron F, L’ollivier C, Mandelbrot L, Wallon M, Piarroux R, Kieffer F, et al. Maternal and congenital toxoplasmosis: Diagnosis and treatment recommendations of a French multidisciplinary working group. Pathogens. 2019;8:1-15. https://doi.org/10.3390/pathogens8010024

Cabra-Bautista G, Paz-Córdoba BE, Henao-Pabón T, Bravo AM, Flórez ID, Delgado-Noguera M, et al. Quality of clinical practice guidelines for gestational and congenital toxoplasmosis: A systematic review of the literature. J Eval Clin Pract. 2022;28:218-24. https://doi.org/10.1111/jep.13612

Cogollo-Jiménez S, Díaz Restrepo E, Pérez Capachero M. Compliance with the Clinical Practice Guideline for Congenital Toxoplasmosis in Colombia in the last twenty years (tesis). Montería: Universidad de Córdoba; 2020.

Wang T, Tan J, Liu XL, Zhao I. Barriers and enablers to implementing clinical practice guidelines in primary care: An overview of systematic reviews. BMJ Open. 2023;13: e062158. https://doi.org/10.1136/bmjopen-2022-062158

Liu XL, Wang T, Tan JY, Stewart S, Chan RJ, Eliseeva S, et al. Sustainability of healthcare professionals’ adherence to clinical practice guidelines in primary care. BMC Prim Care. 2022;23:1-17. https://doi.org/10.1186/s12875-022-01641-x

Mejía-Oquendo M, Marulanda-Ibarra E, Gómez-Marín JE. Evaluation of the impact of the first evidence-based guidelines for congenital toxoplasmosis in Armenia (Quindío) Colombia: An observational retrospective analysis. Lancet Reg Heal-Am. 2021;1:100010. https://doi.org/10.1016/j.lana.2021.100010

Peyron F, Mc Leod F, Ajzenberg D, Contopoulos-Ioannidis D, Kieffer F, Mandelbrot L, et al. Congenital toxoplasmosis in France and the United States: One parasite, two diverging approaches. PLoS Negl Trop Dis. 2017;11:1-6. https://doi.org/10.1371/journal.pntd.0005222

Hernández A, Thota P, Pellegrino D, Pasupuleti V, Benites-Zapata V, Deshpande A, et al. A systematic review and meta-analysis of the relative efficacy and safety of treatment regimens for HIV- associated cerebral toxoplasmosis: Is trimethoprim- sulfamethoxazole a real option? HIV Med. 2017;18:115-24. https://doi.org/10.1111/hiv.12402

Cortés LJ. Guía para la vigilancia por laboratorio de Toxoplasma gondii. Bogotá, D.C.: Instituto Nacional de Salud; 2017. p. 1-19.

Baquero-Artigao F, Del Castillo F, Fuentes I, Goncé A, Fortuny C, Fernández-Miranda M, et al. Guide of the Spanish Society of Pediatric Infectious Diseases for the diagnosis and treatment of congenital toxoplasmosis. An Pediatr. 2013;79:116.e1-116e16. https://doi.org/10.1016/j.anpedi.2012.12.001

Araujo DR, Oliveira R, Soares C, Vieira WF, García LM. Knowledge gaps and educational opportunities in congenital toxoplasmosis: A narrative review of Brazilian and global perspectives. Trop Med Infect Dis. 2024;9:1-17 https://doi.org/10.3390/tropicalmed9060137

How to Cite
1.
Correa-Pérez S, Carrascal-Petro MD, Arango-Ferreira C, Beltrán-Arroyave CP, Sierra-Abaunza JM. Adherence to the Colombian guideline on congenital toxoplasmosis. Biomed. [Internet]. 2025 Sep. 22 [cited 2026 Jan. 15];45(4):574-83. Available from: https://revistabiomedicaorg.biteca.online/index.php/biomedica/article/view/7590

Some similar items:

Published
2025-09-22
Section
Original articles

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
Crossref Cited-by logo
Escanea para compartir
QR Code